Stay updated on Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Sign up to get notified when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 is added to the study's record history, replacing the previous v3.5.3. This reflects an updated version label for the page rather than substantive changes to the study data.
    Difference
    0.1%
    Check dated 2026-05-15T23:53:37.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Version 57 was added on 2026-05-01, and the record now shows a QC status of Has Not Concluded. The history presents expanded content areas such as Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Eligibility, Arms and Interventions, Study Design, Study Description, Study Status, and related document sections.
    Difference
    1.0%
    Check dated 2026-05-08T23:10:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s build/release “Revision” indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance/software version bump rather than a change to the displayed trial record history content.
    Difference
    0.1%
    Check dated 2026-04-24T16:41:34.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The history now shows Results Submitted and Revision: v3.5.2, replacing No Results Posted and Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:29:12.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the history list.
    Difference
    0.1%
    Check dated 2026-03-19T19:22:42.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The new screenshot shows Revision: v3.4.3 in the history, replacing Revision: v3.4.2. This is a small metadata update documenting the latest version.
    Difference
    0.1%
    Check dated 2026-03-12T10:43:07.000Z thumbnail image

Stay in the know with updates to Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2 NSCLC Platform Study Post-Osimertinib Clinical Trial page.